APA

Necchi A., Miceli R., Bregni M., Bokemeyer C., Berger L. A., Oechsle K., Schumacher K., Kanfer E., Bourhis J. H., Massard C., Laszlo D., Montoro J., Flechon A., Arpaci F., Secondino S., Wuchter P., Dreger P., Crysandt M., Worel N., Kruger W., Ringhoffer M., Unal A., Nagler A., Campos A., Wahlin A., Michieli M., Sucak G., Donnini I., Schots R., Ifrah N., Badoglio M., Martino M., Raggi D., Giannatempo P., Rosti G., Pedrazzoli P. & Lanza F. (20161213). Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. : Bone marrow transplantation.

Chicago

Necchi A, Miceli R, Bregni M, Bokemeyer C, Berger L A, Oechsle K, Schumacher K, Kanfer E, Bourhis J H, Massard C, Laszlo D, Montoro J, Flechon A, Arpaci F, Secondino S, Wuchter P, Dreger P, Crysandt M, Worel N, Kruger W, Ringhoffer M, Unal A, Nagler A, Campos A, Wahlin A, Michieli M, Sucak G, Donnini I, Schots R, Ifrah N, Badoglio M, Martino M, Raggi D, Giannatempo P, Rosti G, Pedrazzoli P and Lanza F. 20161213. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. : Bone marrow transplantation.

Harvard

Necchi A., Miceli R., Bregni M., Bokemeyer C., Berger L. A., Oechsle K., Schumacher K., Kanfer E., Bourhis J. H., Massard C., Laszlo D., Montoro J., Flechon A., Arpaci F., Secondino S., Wuchter P., Dreger P., Crysandt M., Worel N., Kruger W., Ringhoffer M., Unal A., Nagler A., Campos A., Wahlin A., Michieli M., Sucak G., Donnini I., Schots R., Ifrah N., Badoglio M., Martino M., Raggi D., Giannatempo P., Rosti G., Pedrazzoli P. and Lanza F. (20161213). Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. : Bone marrow transplantation.

MLA

Necchi A, Miceli R, Bregni M, Bokemeyer C, Berger L A, Oechsle K, Schumacher K, Kanfer E, Bourhis J H, Massard C, Laszlo D, Montoro J, Flechon A, Arpaci F, Secondino S, Wuchter P, Dreger P, Crysandt M, Worel N, Kruger W, Ringhoffer M, Unal A, Nagler A, Campos A, Wahlin A, Michieli M, Sucak G, Donnini I, Schots R, Ifrah N, Badoglio M, Martino M, Raggi D, Giannatempo P, Rosti G, Pedrazzoli P and Lanza F. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. : Bone marrow transplantation. 20161213.